BORDEAUX, France & BOSTON–Regulatory News:Implanet (Euronext Growth: ALIMP, FR0010458729, eligible for PEA-PME equity savings plans; OTCQX: IMPZY) (Paris:ALIMP) (OTCQX:IMPZY), a medical technology company specializing in vertebral and knee surgery implants, announces its participation in the NASS (The North American Spine Society) Annual Congress to be held in Los Angeles from September 26 to 29, 2018.
After the success of the evening, “Jazz® in the treatment of degenerative diseases”, which took place during the Eurospine1congress held from 19 to 21 September in Barcelona, Implanet will present at NASS, Stand # 2024, Jazz® Evo, a new implant developed to meet the constraints of vertebral fusion indications in adults.
The North American Spine Society (NASS) is a medical society that brings together health professionals specialized in the spine. Founded in 1985, NASS aims to promote an ethical and evidence-based therapeutic approach to spinal disorders. The group’s mission is to develop policies and implement initiatives for the teaching, research and advocacy of spinal health specialties.
NASS has more than 8,000 health professionals, orthopedic surgeons and neurosurgeons, psychiatrists, anesthesiologists, researchers and other relevant clinicians.
Next press release: 3rd quarter 2018 revenue on October 9, 2018 before the market opens.
About IMPLANET
Founded in 2007, IMPLANET is a medical technology company that manufactures high-quality implants for orthopedic surgery. Its flagship product, the JAZZ® latest-generation implant, aims to treat spinal pathologies requiring vertebral fusion surgery. Protected by four families of international patents, JAZZ® has obtained 510(k) regulatory clearance from the Food and Drug Administration (FDA) in the United States and the CE mark. IMPLANET employs 46 staff and recorded 2017 sales of €7.8 million. For further information, please visit www.implanet.com. Based near Bordeaux in France, IMPLANET established a US subsidiary in Boston in 2013. IMPLANET is listed on Euronext™ Growth market in Paris. The Company would like to remind that the table for monitoring the BEOCABSA, OCA, BSA and the number of shares outstanding, is available on its website: http://www.implanet-invest.com/suivi-des-actions-80
1 Eurospine is an organisation whose mission is to promote the exchange of knowledge and experience in the field of research, prevention and treatment of spinal disorders and to coordinate efforts at European level.